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Abstract
Background: Three laboratory studies were conducted to assess the repellent and insecticidal efficacy of a
combination of fipronil and permethrin (Frontline Tri- Act®/Frontect®) against three mosquito species (Aedes albopictus,
Aedes aegypti and Culex pipiens) on dogs.
Methods: In each study, 16 healthy adult dogs were allocated to two groups. Eight dogs were treated with the
new topical spot-on combination of fipronil and permethrin on Day 0 and the other eight dogs served as untreated
controls. Each dog was exposed to mosquitoes on Days 1, 7, 14, 21 and 28 (and also on Day 35 in the A. aegypti study).
After a 1-h exposure period, all mosquitoes were counted and categorized as live or dead and fed or non-fed. Live
mosquitoes were kept in an insectary and observed for mortality counts 4, 24 and 48 h post-exposure (PE) for Aedes
spp. and 24 and 48 h PE for C. pipiens. Repellency and insecticidal efficacies were defined as the percent reduction in
the number of fed and live mosquitoes, respectively, in the treated group as compared to the untreated control group.
Results: Repellency against A. albopictus was ≥93.4% through Day 21 and 86.9% on Day 28. It was ≥91.0% through
Day 35 against A. aegypti and ≥90.4% through Day 28 against C. pipiens. Insecticidal efficacy against A. albopictus was
≥97.1% at 24 h PE from Day 7 to Day 28. It was ≥98.0% for the first 3 weeks and still 75.7% on Day 35 against A.
aegypti at 24 h PE. For C. pipiens, insecticidal efficacy ranged from 93.8% (Day 7) to 30.9% (Day 28) at 48 h PE.
Conclusions: A single topical administration of the combination of fipronil and permethrin provides repellency
against mosquitoes on dogs for at least 4 weeks. The product may therefore significantly reduce the potential for the
transmission of vector-borne pathogens through the inhibition of mosquito feeding, as well as the discomfort associated
with mosquito bites. Moreover, mosquito mortality was induced by contact with the treated dogs, which could aid
in the control of mosquitoes, and hence the control of mosquito-borne diseases, in the local vicinity of treated dogs.
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Abrégé
Contexte: Trois études expérimentales ont été conduites afin de mesurer l’efficacité répulsive et insecticide d’une
combinaison de fipronil et perméthrine (Frontline Tri- Act®/Frontect®) contre trois espèces de moustiques (Aedes
albopictus, Aedes aegypti et Culex pipiens) chez le chien.
Méthodes: Les protocoles des études étaient similaires. Dans chaque étude, 16 chiens adultes en bonne santé ont
été répartis en deux groupes. Huit chiens ont été traités avec la nouvelle combinaison spot-on topique de fipronil
et perméthrine au jour 0 et les huit autres chiens servaient de témoins non traités. Chaque chien a été exposé aux
moustiques aux jours 1, 7, 14, 21 et 28 (également au jour 35 dans l’étude A. aegypti). Après une période d’une heure
d’exposition, tous les moustiques ont été comptés et catégorisés : vivants ou morts, gorgés ou non gorgés. Les
moustiques vivants ont été placés en insectarium et leur mortalité observée 4, 24 et 48 h post-exposition (PE) pour
Aedes spp. et 24 et 48 h PE pour C. pipiens. Les efficacités répulsives et insecticides sont respectivement définies comme
le pourcentage de réduction du nombre de moustiques gorgés ou vivants dans le groupe traité comparé au groupe
témoin non traité.
Résultats: La répulsivité contre A. albopictus était≥ 93,4% jusqu’au jour 21 puis 86,9% au jour 28. Elle était≥ 91,0% jusqu’au
jour 35 pour A. aegypti et≥ 90,4% jusqu’au jour 28 pour C. pipiens. L’efficacité insecticide vis-à-vis de A. albopictus était≥
97,1% 24 h PE du jour 7 au jour 28. Elle était≥ 98,0% pendant les 3 premières semaines et 75,7% au jour 35 vis-à-vis de A.
aegypti 24 h PE. Pour C. pipiens, l’efficacité insecticide était de 93,8% (jour 7) à 30,9% (jour 28) 48 h PE.
Conclusions: Dans cette étude, une administration topique unique de la combinaison de fipronil et perméthrine a permis
une activité répulsive d’au moins 4 semaines contre les moustiques chez le chien. Le produit pourrait de ce fait réduire
significativement leur potentiel de transmission d’agents pathogènes vectorisés, par l’inhibition du gorgement des
moustiques, mais réduire aussi l’inconfort lié aux piqûres de moustiques. De plus, le contact avec le chien traité a provoqué
la mort des moustiques. Ce bénéfice pourrait apporter une aide dans la lutte contre les moustiques dans l’environnement
proche du chien traité et dans le contrôle des maladies transmises par les moustiques, menaces émergentes pour la santé
humaine et animale.
Background
Mosquitoes form a monophyletic family of insects, Culici-
dae, that inhabit practically every region of every contin-
ent in the world except Antarctica and are of significant
importance in human and veterinary medicine [1]. Mos-
quito bites can cause pets discomfort and irritation, and
can lead to hypersensitivity reactions in some animals.
More importantly, mosquitoes are vectors of several path-
ogens of considerable importance to pets, including hel-
minths such as Dirofilaria repens (subcutaneous filarial
worm) and Dirofilaria immitis (heartworm) as well as sev-
eral viruses affecting both humans and dogs.
Dirofilaria repens infection is typically confined to the
subcutaneous tissues in dogs and infected animals may be
apparently healthy or may develop skin conditions of vary-
ing severity [2]. The infection is zoonotic and can cause an
array of clinical signs in humans, from benign to very se-
vere conditions. The number of reported cases has been in-
creasing in recent years. Culex and Aedes are the main
species involved in the transmission of D. repens in both
animals and humans [3]. Heartworm disease is a severe and
potentially fatal disease in dogs that is endemic in the
United States of America (USA), much of southern Europe,
Australia, several countries in South America, and in many
countries in Asia [4]. While many species of mosquitoes
can transmit heartworms, Aedes aegypti, Aedes albopictus
and Culex pipiens are among the most important vectors in
many parts of the world [5-10]. For example, it was recently
demonstrated that C. pipiens is the most efficient natural
vector of D. immitis in endemic areas of Italy based on its
high feeding rate on dogs and the detection rate of D.
immitis in sampled mosquitoes [11]. Although less import-
ant in pets than in human health, arboviruses may also
cause severe disease in dogs. Mosquito-borne viruses of
pets are found in three viral families: Alphaviridae, Flaviviri-
dae and Bunyaviridae [12]. Among Alphaviridae, viruses
from the complexes responsible for equine encephalitis
transmitted by Aedes spp. and Culex spp. may cause se-
vere neurological signs in dogs. The West Nile virus and
Japanese encephalitis virus from the Flaviviridae family are
mainly transmitted by Culex spp. West Nile virus has
spread from Africa to Europe, Asia and North America.
Seroprevalence in dogs in endemic areas is high and clin-
ical cases, despite being rare, may be severe. Three mem-
bers of the Bunyaviridae family are known to cause
diseases in dogs: the Lacrosse encephalitis virus transmit-
ted by Aedes triseriatus in North America, the Tensaw
virus transmitted by Anopheles spp. in Southeastern
United States and the Rift Valley fever virus transmitted
by Culex spp. and Aedes spp. in Eastern Africa [12].
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Aedes albopictus, the Asian tiger mosquito, probably pre-
sents the most important threat of any mosquito species to
public health in Europe. It is considered to be the most in-
vasive mosquito species in the world and, despite the efforts
made in controlling its spread, it is now well established in
new territories, and in Europe its control is a major concern
of authorities [13]. It originated in Southeast Asia but in
the last 30 years has spread into Europe, North and South
America, Africa, and a number of locations in the Pacific
and Indian Oceans [14]. Unlike most mosquito species, A.
albopictus feed during the day, thus rendering previous pre-
vention strategies such as keeping animals indoors at night
ineffective [11]. The rapid spread, aggressive nature, ability
to transmit both helminthic and viral pathogens and the di-
urnal feeding behavior of A. albopictus make it a particular
concern for pet dogs.
An integrated approach to vector and transmitted patho-
gen control, consisting of using all available management
strategies to limit the disease burden, including the add-
itional application of a parasiticide with repellent (i.e. anti-
feeding) effect against mosquitoes, can help provide optimal
protection against vector-borne diseases for dogs and
humans in endemic areas. In addition, products that can po-
tentially impact the mosquito population in the local vicinity
of treated dogs are of interest as well.
Permethrin is a Type 1 pyrethroid, which is an insecti-
cide and acaricide with repellent activity. Permethrin has
been applied in different formulations for the control of
ectoparasites on both companion and production animals,
as well as humans. Both single-active formulations, as well
as combination products, have been shown to effectively
control mosquitoes [9,15,16]. Fipronil, a phenylpyrazole,
has both insecticidal and acaricidal activity. Fipronil has
been used in spray and spot-on formulations to control
fleas and ticks on companion animals [17-20].
A novel combination of 6.76% w/v fipronil and 50.48%
w/v permethrin (Frontline Tri- Act®/Frontect®)) has been de-
veloped for use as a monthly topical solution for dogs to
provide broad spectrum ectoparasite control. The studies re-
ported here were conducted to assess the repellent and in-
secticidal efficacies of this combination against three species
of mosquitoes (A. albopictus, A. aegypti and C. pipiens).
Methods
Study design
Three studies, each with a similar study design, were con-
ducted. Study 1 used A. albopictus mosquitoes, Study 2 used
A. aegypti mosquitoes, and Study 3 used C. pipiens quinque-
fasciatus mosquitoes (part of the C. pipiens complex; these
mosquitoes will be referred to simply as C. pipiens in this
and the other sections of this manuscript). Studies 1 and 2
were conducted in the USA and Study 3 was conducted
in Switzerland. All studies were conducted in accordance
with Good Clinical Practices (GCP) as described in the
International Cooperation on Harmonisation of Tech-
nical Requirements for Registration of Veterinary Medi-
cinal Products (VICH) guideline 9.
Animals
For each study, 18 dogs were exposed to mosquitoes prior
to enrollment to assess their susceptibility to mosquito feed-
ing. The two dogs with the lowest number of fed mosqui-
toes after this exposure were dropped from the study. The
remaining 16 dogs were ranked by descending fed mosquito
count and eight blocks of two dogs each were formed.
Within blocks, each dog was randomly allocated to one of
two groups. The enrolled dogs were healthy Beagle dogs
with a mixture of males and females in each study (10 males
and 6 females in Study 1; 9 males and 7 females in Study 2;
7 males and 9 females in Study 3) and had not been exposed
to ectoparasiticides in the 3 months prior to the study. The
dogs were managed with due regard for their well-being, in
accordance with Merial and local Institutional Animal Care
and Use Committee requirements. Dogs were housed indi-
vidually in Studies 1 and 2, and were housed in groups of 2
or 3 within treatment group in Study 3 (C. pipiens) due to
local laws restricting individual housing. A veterinary exam-
ination was performed prior to the start of each study to
ensure that all dogs were healthy and suitable for inclusion
in the study. The dogs were observed daily for any health
changes throughout each study.
Treatment
Dogs in Group 1 received no treatment and served as un-
treated controls. Dogs in Group 2 were treated once with
a topical formulation containing 6.76% w/v fipronil and
50.48% w/v permethrin. In Studies 1 and 2 (A. albopictus
and A. aegypti, respectively), the dogs were treated with
the commercial dose of the product based on their body
weight. In Study 3 (C. pipiens), each dog was dosed with
the minimum dose of the product (0.1 ml/kg; 6.76 mg/kg
fipronil, 50.48 mg/kg permethrin) once topically. In each
study, the total volume of the product was divided into
two approximately equal fractions and placed on the skin
on the midline of the neck. One fraction was applied be-
tween the base of the skull and the shoulder blades and
the other was applied at the front of the shoulder blades.
All dogs were observed hourly for any adverse reaction for
4 h post-treatment.
Mosquitoes
All mosquitoes were laboratory-reared. Five-to-10-day old
female A. albopictus were used in Study 1. The A. albopic-
tus mosquitoes were sourced as eggs from three labora-
tory colonies in the USA (Gainesville and Vero Beach,
Florida, and Raleigh, North Carolina). Four-to-5-day old
female A. aegypti (Liverpool black-eyed strain) were used
in Study 2. Seven-to-14-day old female C. pipiens were
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used in Study 3. This strain was isolated from California,
USA, and has been maintained in Toulouse, France, since
1984, and in Zurich, Switzerland, since 2011.
Mosquito exposures and counts
Dogs were exposed to mosquitoes on Days 1, 7, 14, 21 and
28 (and also on Day 35 in Study 2). Prior to exposure, each
dog was anesthetized using one of the following combina-
tions administered intramuscularly: 11 mg/kg ketamine
(Ketaset®, Zoetis) and 2.2 mg/kg xylazine (Xylazine-20, But-
ler Co.); 0.02 mg/kg dexmedetomidine (Dexdomitor®, Orion
Corporation) and 0.2 mg/kg butorphanol (Butorphic®, Lloyd
Laboratories); 2.9 mg/kg ketamine (Ketaset®, Zoetis)
and 1.1 mg/kg xylazine (AnaSed®,Lloyd Laboratories);
or 0.04 mg/kg medetomidine (Dorbene®, Graeub) and
0.2 mg/kg butorphanol (Morphasol-4®, Graeub). Add-
itional amounts of the anesthetics were administered as
needed to maintain anesthesia for the duration of the
exposure period. Once anesthetized, each dog was
placed into an individual mosquito proof exposure cage
and mosquitoes (approximately 100 female A. aegypti or
C. pipiens, and approximately 75 female A. albopictus)
were released into the exposure cage. After the 1-hour
exposure period, live mosquitoes were counted and cat-
egorized as fed or non-fed and then held in a container
in an insectary for subsequent mortality counts. Dead
mosquitoes remaining in the cage or on the dog were
counted and categorized as fed or non-fed. Any mosqui-
toes that were physically crushed by the dog were noted
but were not used in the assessment of repellency or in-
secticidal efficacy. At approximately 4, 24 and 48 h
post-exposure (PE) for Studies 1 and 2 (Aedes spp.) and
24 and 48 h for Study 3 (C. pipiens), the number of dead
mosquitoes in each holding container was counted and
used to determine the number of mosquitoes remaining
alive. In Studies 2 and 3, whether live mosquitoes had
fed or not was visually determined immediately after the
exposure period. In Study 1 (A. albopictus), the live
mosquitoes were very active and difficult to count. To
improve accuracy of the counts of this species, live mos-
quitoes were frozen after the last mortality count and
counted as fed or non-fed after freezing (engorgement
status can be evaluated up to 48 h post-blood feeding).
All personnel conducting mosquito counts and health
observations were blinded to treatment groups.
Data analysis
Percent mosquito repellency was defined as the percent re-
duction in the number of fed mosquitoes in the treated
group as compared to the untreated control group. The
total numbers of fed (live + dead) mosquitoes at the end of
each exposure period were transformed to the natural loga-
rithm of (count + 1) for calculation of geometric means
(GM) by treatment group. Percent repellency at each post-
treatment exposure day was calculated as 100 × [(C – T)/C],
where C is the GM of the control group and T is the GM of
the treated group. Crushed mosquitoes were not included in
the analysis.
Percent insecticidal efficacy was defined as the percent
reduction in live mosquitoes in the treated group as com-
pared to the untreated control group. The number of live
mosquitoes at each time point (4, 24 and 48 h in Studies 1
and 2, and 24 and 48 h in Study 3) after each post-
treatment exposure was transformed to the natural loga-
rithm of (count + 1) for calculation of GM by treatment
group at each time point of each post-treatment exposure.
Percent insecticidal efficacy of the treated group compared
to the control group at each time point of each post-
treatment exposure was calculated as 100 x [(C – T)/C],
where C is the mean of the control group and T is the
mean of the treated group.
For both repellency and insecticidal efficacy, the treated
group was compared to the untreated control group using
the Friedman rank test with blocks defined as the allocation
blocks. The testing was two-sided and used a significance
level of 5%. The analyses were performed using SAS® Ver-
sion 9.1.3.
Results
Repellency
There was a significant difference between the population
means of the treated and control groups at every time
point (p = 0.005) for each mosquito species.
The mosquito challenge was evaluated by the number of
fed mosquitoes in the untreated control dogs at the end of
each exposure period. The GM of fed mosquitoes in the un-
treated control dogs ranged from 18.3 to 38.0 in Study 1 (75
A. albopictus used for each exposure), from 68.2 to 85.3 in
Study 2 (100 A. aegypti used for each exposure), and from
23.9 to 76.8 in Study 3 (100 C. pipiens used for each expos-
ure) (Tables 1, 2 and 3).
Aedes albopictus
The GM number of fed A. albopictus in each group and
the percent repellency after the 1 h exposure period on
each exposure day are shown in Table 1. Repellency was
93.4%, 96.5%, 99.5%, 96.6% and 86.9% on Days 1, 7, 14,
21 and 28, respectively.
Aedes aegypti
The GM number of fed A. aegypti in each group and the
percent repellency after the 1 h exposure period on each
exposure day are shown in Table 2. Repellency was
99.9%, 100%, 99.0%, 98.5%, 96.1% and 91.0% on Days 1,
7, 14, 21, 28 and 35, respectively.
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Culex pipiens
The GM number of fed C. pipiens in each group and the
percent repellency after the 1 h exposure period on each
exposure day are shown in Table 3. Repellency was
99.4%, 98.9%, 94.7%, 91.7%, and 90.4% on Days 1, 7, 14,
21, and 28 respectively.
Insecticidal efficacy
In each study, high numbers of mosquitoes exposed to
the untreated control dogs remained alive at all PE time
points after each exposure except on Day 1 for A. albo-
pictus (Study 1). In this study, no evaluation was per-
formed on the data collected after the Day 1 exposure
because all of the mosquitoes in the control group were
dead at the end of the PE holding period (48 h). This
was likely due to dehydration of the mosquitoes as the
source of water and carbohydrate dried out more quickly
than anticipated. In the subsequent exposures, these
sources were replenished frequently and no additional
problems with mosquito mortality in the control group
were noted.
Treated dogs had significantly fewer live mosquitoes
than untreated control dogs in all studies and for all
study days and time points. The percent insecticidal effi-
cacy for each mosquito species at each time point for
each exposure day is shown in Table 4.
Aedes albopictus
The insecticidal efficacy against A. albopictus was above
91.1% for 4 weeks after treatment at 4 h PE and was ≥
97.1% and ≥ 97.8% for 4 weeks after treatment at 24 and
48 h, respectively.
Aedes aegypti
The percent insecticidal efficacy against A. aegypti on
treated dogs was ≥93.8% at 4 h after exposure on Days 1
and 7. At 24 h PE, insecticidal efficacy was ≥98.0%
through Day 21 and still 79.8% at Day 28 and 75.7% on
Day 35. At 48 h PE, it was ≥ 86.6% for 28 days after
treatment and remained at 84.7% on Day 35.
Culex pipiens
For C. pipiens, no calculation of the insecticidal efficacy
was done at 4 h PE because visual observations sug-
gested a too limited efficacy at this early time point. The
percent insecticidal efficacy was 77.9% and 79.4% at 24
and 48 h PE, respectively, on Day 1; and 92.1% and
93.8% at 24 and 48 h PE, respectively, on Day 7. Insecti-
cidal efficacy ranged from 93.8% to 30.9%, at 48 h PE
during the whole month.
No adverse reactions to the topical treatment were ob-
served in any dog in any of the three studies, including
during the 48 h immediately after treatment.
Table 1 Percent repellency of Aedes albopictus in dogs treated with a new combination of fipronil and permethrin
Exposure day GM of numbers of fed mosquitoes1 Repellency (%)
Untreated control dogs Treated dogs
(n = 8) (n = 8)
1 18.3 1.2 93.4*
7 20.8 0.7 96.5*
14 28.8 0.1 99.5*
21 38.0 1.3 96.6*
28 23.0 3.0 86.9*
1Geometric Means of mosquitoes collected at the end of the 1-h exposure period. 75 mosquitoes per dog were used for each exposure.
*Significant difference between the population means of the treated and control groups (p = 0.005).
Table 2 Percent repellency of Aedes aegypti in dogs treated with a new combination of fipronil and permethrin
Exposure day GM of numbers of fed mosquitoes1 Repellency (%)
Untreated control dogs Treated dogs
(n = 8) (n = 8)
1 68.2 0.1 99.9*
7 84.4 0.0 100*
14 83.9 0.8 99.0*
21 80.6 1.2 98.5*
28 83.0 3.3 96.1*
35 85.3 7.7 91.0*
1Geometric Means of mosquitoes collected at the end of the 1-h exposure period. 100 mosquitoes per dog were used for each exposure.
*Significant difference between the population means of the treated and control groups (p = 0.005).
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Discussion
The results of the three studies demonstrate that a single
topical treatment of the combination of fipronil and per-
methrin (Frontline Tri-Act®/Frontect®) provides excellent
repellency (inhibition of feeding) against mosquitoes for
at least 4 weeks. The product provided immediate effects
after administration as demonstrated by the high percent
repellency in each study one day after treatment. Repel-
lency on Day 1 was 93.4% against A. albopictus, 99.9%
against A. aegypti and 99.4% against C. pipiens. The
repellent effects persisted for at least 28 days after
treatment with 86.9% repellency against A. albopictus,
96.1% repellency against A. aegypti and 90.4% repellency
against C. pipiens on Day 28. Study 2 was extended due
to the excellent repellency on Day 28 and repellency
against A. aegypti remained high at 91.0% on Day 35 after
treatment.
The repellency of the fipronil and permethrin combin-
ation against A. aegypti was similar to, or higher than, previ-
ously reported for other commercial permethrin-containing
products [9,15,16]. The repellency of a single-active 65%
permethrin product ranged from 78.0% to 89.9% until Day
21 and then declined to 61.9% on Day 28; for a combination
of permethrin and imidacloprid, repellency ranged from
84.9% to 94.1% through Day 21 and then declined to 50.4%
on Day 28; and for a combination of permethrin, dinote-
furan and pyriproxyfen repellency ranged from 91.5% to
94.0% through Day 21 and remained at 87.0% on Day 28
[9,15,16]. The excellent duration of effect of the new com-
bination may relate to the product’s formulation, the com-
bination of the effects of permethrin with those of fipronil,
or other factors. Fipronil is a broad spectrum insecticide and
has been reported to have activity against mosquitoes [21].
Combining two active ingredients that both have activity
against mosquitoes may lead to improved activity of the
product for a longer duration.
In addition to the strong repellent efficacy, the product
demonstrated high insecticidal efficacy on mosquitoes
that have been in contact with treated dogs (even those
mosquitoes that are repelled). This efficacy was ≥91.1%
on A. albopictus as early as 4 h after exposure for at
least 1 month after application of the product. It was
≥79.8% at 24 h post exposure on A. aegypti at Day 28
exposure and, while lower, still provided significant mor-
tality effect on C. pipiens with an insecticidal efficacy be-
tween 92.1% and 26.9% for a full month (28 days) at
24 h PE. There is no clear explanation of the difference
in insecticidal efficacy against Aedes spp. and Culex
Table 3 Percent repellency of Culex pipiens in dogs treated with a new combination of fipronil and permethrin
Exposure Day GM of numbers of fed mosquitoes1 Repellency (%)
Untreated control dogs Treated dogs
(n = 8) (n = 8)
1 23.9 0.1 99.4*
7 45.2 0.5 98.9*
14 52.7 2.8 94.7*
21 76.8 6.4 91.7*
28 62.5 6.0 90.4*
1Geometric Means of mosquitoes collected at the end of the 1-h exposure period. 100 mosquitoes per dog were used for each exposure.
*Significant difference between the population means of the treated and control groups (p = 0.005).
Table 4 Percent insecticidal efficacy of Aedes albopictus, Aedes aegypti and Culex pipiens in dogs treated with a new
combination of fipronil and permethrin
Species Time post
exposure1
Percent insecticidal efficacy2
Day 1 Day 7 Day 14 Day 21 Day 28 Day 35
A. albopictus 4 h ND3 100* 93.2* 93.7* 91.1* ND
24 h ND3 100* 97.1* 100* 100* ND
48 h ND3 100* 97.8* 100* 100* ND
A. aegypti 4 h 99.8* 93.8* 69.5* 77.0* 20.9* 27.1*
24 h 99.7* 99.9* 98.0* 98.5* 79.8* 75.7*
48 h 99.7* 99.8* 99.1* 99.3* 86.6* 84.7*
C. pipiens 24 h 77.9* 92.1* 34.7* 38.5* 26.9* ND
48 h 79.4* 93.8* 37.3* 45.0* 30.9* ND
1Mosquitoes were collected at the end of the 1-h exposure period. 2Based on geometric means.
3Analysis not performed on these days.
*Significant difference between the population means of the treated and control groups (p = 0.005).
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pipiens. Interestingly, similar results were observed in
preliminary studies performed in another laboratory
(data not shown). One hypothesis is that the repellent
effect is stronger on C. pipiens, preventing them to land
on the treated animals as is the case for Aedes spp.,
therefore limiting their contact with the insecticidal
molecules.
The mosquito challenge was robust on all exposure days.
A high percentage of the mosquitoes fed on the untreated
control dogs on each exposure day of each study. The feed-
ing percentages in the current studies are similar to those
reported in previous dog studies using A. aegypti and C.
pipiens [9,15,16,21]. The feeding rate was lower in Study 1,
with a GM of 18.3 to 38.0 (of approximately 75 A. albopictus
used for each exposure) having fed during the exposure
period. The reason for the lower feeding rate of A. albopic-
tus as compared to the other species is unknown. While A.
albopictus will feed on a wide variety of hosts, it has been
shown that they tend to have lower feeding rates in general
than other mosquito species [22,23] Despite the lower feed-
ing rates, the A. albopictus challenge was robust, especially
towards the end of the trial, and allowed for a valid test of
the repellency of the product.
The product’s repellent effects will help prevent mosqui-
toes from biting and taking a blood meal from treated
dogs, thus protecting dogs from bites that can be painful
and cause inflammation and allergic reactions in some an-
imals. In addition, as stated by the WHO, disease preven-
tion through vector control is an important component of
disease control and it can reduce disease transmission
[24]. Therefore, this repellent efficacy may contribute to
the protection of dogs against major diseases transmitted
by mosquitoes. In addition, the insecticidal efficacy, illus-
trating the ability of the product to kill mosquitoes, may
be helpful to control the number of mosquitoes in the
local vicinity of the treated dog.
The control of A. albopictus in particular poses a serious
problem [13,25]. This species has become an emerging and
important vector in many parts of the world. The biology
and behavior of this particular species makes the surveil-
lance and control of it hugely important. The tiger mos-
quito is very aggressive and feeds during the day, with two
main peaks of activity in the morning and early evening
[7,23]. It originated in Southeast Asia but has rapidly spread
into many other regions of the world. It has been detected
much farther north than other similar species (A. aegypti,
for example), likely due to the fact that it can readily adapt
to colder temperatures by becoming dormant in the winter.
The species can be difficult to control as it can utilize a
large variety of larval breeding sites, from natural sites, such
as tree stumps and holes, to artificial containers, such as
water storage containers and old pieces of automobiles
[14]. It has been shown to be a very competent vector of
multiple viruses affecting humans, including dengue virus,
chikungunya virus, West Nile virus and others, and has been
shown to feed on a variety of hosts. It prefers mammals, but
will feed on most vertebrate hosts, including reptiles, birds
and amphibians. This not only increases fecundity and sur-
vivability of the species, but also increases the risk that it will
propagate zoonotic pathogens [14]. This report demon-
strates that the combination of permethrin and fipronil and
permethrin provides a high level of repellency and insecti-
cidal efficacy against this emerging and difficult to control
species in treated dogs for at least 4 weeks.
Conclusions
The results of the three studies reported here demonstrate
that a single topical treatment of a new combination of
fipronil and permethrin (Frontline Tri- Act®/Frontect®) pro-
vides excellent repellency (inhibition of feeding) and insecti-
cidal efficacy against mosquitoes on dogs for at least
4 weeks. The product may therefore significantly reduce
the potential for the transmission of vector-borne diseases
through the inhibition of mosquito feeding as well as redu-
cing the discomfort and possible hypersensitivity reactions
associated with mosquito bites.
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